George Fritsma and guest speaker Karen Moser, MD, Medical Director of the Hemostasis and Thrombosis Laboratory at ARUP Laboratories and Associate Professor of Pathology at
Posts - Anticoagulant Therapy
Sep 19, 2022 9:15am
Aug 4, 2022 1:54pm
Here is a breakthrough study from Tunisia indicating the efficacy of sulodexide [Aterina], the oral "fast-moving heparin"-dermatan sulfate formulation, in managing the endothelial dysfunction of and reducing the symptoms associated with Long Covid. Sulodexide is not FDA-approved for Long Covid therapy.
Aug 4, 2022 1:34pm
On Wednesday, 8-3-22, the ISTH published comprehensive guidelines recommending for or against antithrombotic agents for Covid at
Jun 17, 2022 8:16pm
Does your facility measure rivaroxaban or apixaban using a chromogenic substrate anti-Xa assay based on unfractionated heparin [UFH ] calibrators or UFH-low molecular weight heparin [UFH-LWMH] 'hybrid" calibrators, or do you require rivaroxaban and apixaban calibrators?